Legislation on Genetic Diagnosis: Comparison of South Korea and Germany: - With Focus on the Application and Communication Structure
- PMID: 27004267
- PMCID: PMC4801049
- DOI: 10.12717/DR.2015.19.2.111
Legislation on Genetic Diagnosis: Comparison of South Korea and Germany: - With Focus on the Application and Communication Structure
Abstract
This article explores the questions regarding PND and PID, especially the concrete legal conditions for the justification of PND and PID. As such, the German law stipulating PND and PID in a very concrete and detailed manner is introduced and explained in comparison with the corresponding South Korean law. The South Korean Bioethics and Biosafety Act (BBA) stipulates various types of gene testing and does not demonstrate a delicate sense of each type of gene testing. In contrast to the South Korean regulation, in Germany, there exist specific regulations for genetic counseling. Especially in the case of PND, GEKO stipulates the process of genetic counseling very concretely, based on GenDG. In the case of PND and PID, it is important that the people concerned understand the meaning of testing in various angles, and restructuralize it by combining it with their own values as the diagnosis is directly combined with pregnancy/abortion, which influences the whole life of a woman (and her partner). In this context, the South Korean BBA needs to be amended as soon as possible. The sections on informed consent also need to be amended to make them more concrete. Furthermore, guidelines for concretizing the regulation of BBA need to be continuously formulated and developed.
Keywords: Bioethics; Bioethics and Biosafety Act; Gendiagnostikgesetz; Gene Testing; Genetic Diagnosis; PID; PND.
References
-
- Cho SY. Regulation of gene data bank by criminal process law in Germany. Criminology. 2007;19:155–182.
-
- GEKO (Gendiagnostik Kommission am Robert Koch-Institut) Richtlinie der Gendiagnostik-Kommission (GEKO) über die Anforderungen an die Qualifikation zur und Inhalte der genetischen Beratung der gene-tischen Beratung gemäß §23 Abs.2 Nr.2a und §23 Abs.2 Nr.3 GenDG. Bundesgesundheitsblatt. 2011a;54:1248–1256. - PubMed
-
- GEKO. Richtlinie der Gendiagnostik-Kommission (GEKO) für die Beurteilung genetischer Eigenschaften hinsichtlich ihrer Bedeutung nach §15 Abs.1 Satz1 GenDG für eine Beeinträchtigung der Gesundheit des Embryos oder des Fötus während der Schwangerschaft oder nach der Geburt gemäß §23 Abs.2 Nr.1d GenDG. Bundesgesundheitsblatt. 2013b;56:1028–1029. - PubMed
-
- GEKO. Bekanntnachung eines Beschlusses der Gendiagnostik-Kommission (GEKO) vom 16.11.2012 über dier Anforderungen an die Inhalte der Aufklärung bei genetischen Untersuchungen zu medizinischen Zwecken gemäß §23 Abs.2 Nr.3 GenDG vom 27.04. 2012. Bundesgesundheitsblatt. 2013c;56:325–330. - PubMed
-
- GEKO. Richtlinie der Gendiagnostik-Kommission (GEKO) für die Anforderungen an die Durchführung der vorge-burtlichen Risikoabklärung sowie an die insoweit erfor-derlichen Maßnahmen zur Qualitätssicherung gemäß §23 Abs.2 Nr.5 GenDG. RicBundesgesundheitsblatt. 2013a;56:1023–1027. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials